Having shown preclinical promise, the first clinical data are now in on natural killer cells equipped with a chimeric antigen receptor targeting CD19. Albeit in a small number of patients so far, the experimental immunotherapy has elicited a high response rate with little to no toxicity.

中文翻译：

---

癌症免疫疗法：为CAR NK铺路。

已经显示出临床前的希望，现在有关配备靶向CD19的嵌合抗原受体的自然杀伤细胞的第一批临床数据已经出现。迄今为止，尽管在少数患者中，实验性免疫疗法已经引起了高反应率，几乎没有毒性。